Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

Johnson & Johnson (JNJ) 89.36 0.79
Price Open:88.70Day's Range:67.80 - 89.87000
Price Close:88.5952wk Range:61.05 - 89.87000
Price Day Change:0.79Volume:4,298,638
Price % Change:0.89Market Cap:251.1B
Bid:89.35000PE Ratio:24.06
Ask:89.36000EPS Diluted:3.682
Trade JNJ NOW!

The Latest On JNJ

J&J's Janssen Announces Primary Efficacy, Safety Findings from Phase 3 Study of Simeprevir Once Daily 5/21/13 8:18am
How Understanding the Investment Climate Equals Stock Market Success 5/20/13 9:34am
Short Interest in Vertex Rises, in Celgene Falls 5/11/13 10:45am
S&P Highlights Biotech ETFs 5/10/13 7:39am
Stock Market Fake-Out: Where Is the Retrenchment? 5/8/13 12:47pm
Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio 5/8/13 4:51am
Three Top Performing Healthcare Stocks to Watch 5/6/13 3:53pm
Earnings Trigger Volume Spike in Pharma ETF 5/1/13 2:41pm
Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma from U.S. Food and Drug Administration 5/1/13 12:08pm
First Manhattan Responds to VIVUS Board Additions, Says Board Still Needs Overhaul 5/1/13 8:49am
Short Sellers Move into Celgene, Regeneron 4/26/13 1:25pm
Yes, This ETF Offers Dividend Growth 4/25/13 2:00pm
more
Press Releases
Davis Names Top 25 Brand Leaders for 2012 5/7/13 Business Wire
Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL) 5/2/13 Newswire
First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus' Board at the 2013 Annual Meeting 5/1/13 Business Wire
First Manhattan Comments on Addition to Vivus' Board of Directors 5/1/13 Business Wire
Johnson & Johnson Announces Dividend Increase of 8.2% 4/25/13 Newswire
Johnson & Johnson to Host Pharmaceuticals Business Review 4/23/13 Newswire
Johnson & Johnson Announces Sale of Elan American Depositary Shares to Elan 4/18/13 Newswire
Johnson & Johnson Reports 2013 First-Quarter Results: 4/16/13 Newswire
Johnson & Johnson to Webcast Annual Meeting of Shareholders 4/11/13 Newswire
Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures 4/4/13 Newswire
Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results 3/19/13 Newswire
Johnson & Johnson Comments on Venezuelan Currency Devaluation 2/25/13 Newswire

Get the latest JNJ stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Johnson & Johnson stock price.

Partner Headlines
Stock Market News for May 22, 2013 - Market News 5/22/13
J&J, Up 26% YTD, Gets After Image Problems 5/21/13
Roche, Reloaded 5/21/13
JNJ's Simponi Label Expanded - Analyst Blog 5/21/13
Investment That Protects You From Yourself: Bonds 5/21/13
Is There a Pill For That? Forest Labs' Iffy Pipeline 5/21/13
J&J to end metal hip sales 5/17/13
J&J, Up 25% YTD, Shrugs Off Risperdal Suits 5/17/13
Some Dividend ETFs Outperforming The S&P 500 5/16/13
Why would I not sell dividend stocks even after a 1000% gain? 5/15/13
Richard Pzena Buys 5 New Stocks 5/14/13
6 Dividend Stocks to Beat the Wall Street Giants 5/14/13